The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Pestrikova T.Iu.

Kafedra akusherstva i ginekologii Dal'nevostochnogo gosudarstvennogo meditsinskogo universiteta, Khabarovsk

Iurasova E.A.

Kafedra akusherstva i ginekologii Dal'nevostochnogo gosudarstvennogo meditsinskogo universiteta, Khabarovsk

Iurasov I.V.

Kafedra akusherstva i ginekologii Dal'nevostochnogo gosudarstvennogo meditsinskogo universiteta, Khabarovsk

Sukhonosova E.L.

Dal'nevostochnyĭ gosudarstvennyĭ meditsinskiĭ universitet, Khabarovsk

The possibilities of abundant uterine bleeding therapy with combined oral contraceptive containing estradiol valerate and dienogest (a review)

Authors:

Pestrikova T.Iu., Iurasova E.A., Iurasov I.V., Sukhonosova E.L.

More about the authors

Journal: Russian Journal of Human Reproduction. 2017;23(6): 34‑38

Read: 3298 times


To cite this article:

Pestrikova TIu, Iurasova EA, Iurasov IV, Sukhonosova EL. The possibilities of abundant uterine bleeding therapy with combined oral contraceptive containing estradiol valerate and dienogest (a review). Russian Journal of Human Reproduction. 2017;23(6):34‑38. (In Russ.)
https://doi.org/10.17116/repro201723634-38

Recommended articles:
The possibilities of realizing reproductive function in women with endo­metrial hype­rplasia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):98-105

References:

  1. Guide to reproductive medicine. Ed. Carra B. Blackwell R. and Aziza R. Per. with english. M.: Practice; 2015. (In Russ.)
  2. Sharma S, Makaju R, Shrestha S, Shrestha A. Histopathological findings of endometrial samples and its correlation between the premenopausal and postmenopausal women in abnormal uterine bleeding. Kathmandu Univ Med J. 2014;12(48):275-278. https://doi.org/10.3126/kumj.v12i4.137347
  3. Management of acute abnormal uterine bleeding in nonpregnant women. International Journal of Science and Research. 2016;5(3):273-275. https://doi.org/10.21275/v5i3.nov161858
  4. Srivaths LS, Bercaw JL, Dietrich JE. Heavy menstrual bleeding. Management of Bleeding Patients. 2016:199-206. https://doi.org/10.1007/978-3-319-30726-8_22
  5. Gynecology. National leadership: a short edition. Еds. Savelieva GM, Sukhikh GT, Manukhin IB. M: GEOTAR-Media; 2015. (In Russ.)
  6. AlHilli MM, Hopkins MR, Famuyide AO. Endometrial cancer after endometrial ablation: systematic review of medical literature. Gynecologic Oncology. 2011;123(2):443. https://doi.org/10.1016/j.ygyno.2011.07.074
  7. Cooper NA, Barton PM, Breijer M, Caffrey О, Opmeer ВС, Timmermans А, Mol ВWJ, Khan КS, Clark TJ Cost-effectiveness of diagnostic strategies for the management of abnormal uterine bleeding (heavy menstrual bleeding and post-meno-pausal bleeding): a decision analysis. Health Technol Assess. 2014;18(24). https://doi.org/10.3310/hta18240
  8. Garg P, Yadav S. Comparison of transvaginal ultrasonography and hysteroscopy in the evaluation of peri and postmenopausal bleeding. Journal of Evolution of Medical and Dental Sciences. 2016;5(21):1133-1136. https://doi.org/10.14260/jemds/2016/263
  9. Sakhel K, Abuhamad A. Sonography of adenomyosis. J Ultrasound Med. 2012;31:805-808. https://doi.org/10.7863/jum.2012.31.5.805
  10. Weiss G, Maseelall Р, Schott LL, Brockwell SE, Schocken M., Johnston JM. Adenomyosis a variant not a disease? Evidence from hysterectomized menopausal women in the SWAN Study. Fertil Steril. 2009;91(1):201-206. https://doi.org/10.1016/j.fertnstert.2007.11.025
  11. Munro MG, Critchley HO, Broder MS, Fraser IS, for the FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet. 2011;113(1):3-13. https://doi.org/10.1016/j.ijgo.2010.11.011
  12. Pestrikova TYu, Danilenko IA, Boloniaeva NA, Gaponenko EK. Contraception: The effectiveness and safety of the use of an intrauterine levonorgestrel-releasing system. Gynecology. 2015;17(1):22-24. (In Russ.)
  13. Abushahin N, Zhao R, Jia L, Zheng W. Endometrial precancers: from concept to practice. Diagnostic Histopathology. 2013;19(7):256-266. https://doi.org/10.1016/j.mpdhp.2013.06.004
  14. Patel C, Ullal A, Roberts M, Brady J, Birch P, Bulmer JN, Wadehra V Endometrial carcinoma detected with SurePath liquid-based cervical cytology: comparison with conventional cytology. Cytopathology. 2009;20(6):380-387. https://doi.org/10.1111/j.1365-2303.2008.00621.x
  15. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, Alberts D, Curtin J. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia. Cancer. 2006;106(4):812-819. https://doi.org/10.1002/cncr.21650
  16. Hay DL, Walker CS, Poyner DR. Adrenomedullin and calcitonin generelated peptide receptors in endocrinerelated cancers: opportunities and challenges. Endocr Relat Cancer. 2010;18(1):1-14. https://doi.org/10.1677/erc-10-0244
  17. Reproductive Medicine and Family Planning: A Practical Guide. McVay Е, Gillboud D, Hambag R. Ed. Prilepskoy VN. and Sukhikh GT. Trans. with english. М.: MEDPRESS-INFORM, 2016. (In Russ.)
  18. Guide to contraception. Ed. Prilepskaya VN. 3rd ed., Pererab. and additional. М.: MEDPRESS-INFORM, 2014. (In Russ.)
  19. AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of Endometrial Polyps. Journal of Minimally Invasive Gynecology. 2012;19(1):3-10. https://doi.org/10.1016/j.jmig.2011.09.003
  20. Lieng M, Istre O, Sandvik L, Qvigstad E. Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: cross-sectional study. J Minim Invasive Gynecol. 2009;16(4):465-471. https://doi.org/10.1016/j.jmig.2009.04.005
  21. Salim S, Won H, Nesbitt-Hawes E, Campbell N, Abbott J. Diagnosis and management of endometrial polyps: a critical review of literature. J Minim Invasive Gynaecol. 2011;18(5):569-581. https://doi.org/10.1016/j.jmig.2011.05.018
  22. Paradisi R, Rossi S, Scifo MС, C, Dall’O’ F, Battaglia C, Venturoli S. Recurrence of endometrial polyps. Gynecol Obstet Invest. 2014;78(1):26-32. https://doi.org/10.1159/000362646
  23. Yang J-H, Chen C-D, Chen S-U, Yang Y-S, Chen M-J. Factors influencing the recurrence potential of benign endometrial polyps after hysteroscopic polypectomy. PLОS ONE. 2015;10(12):e0144857. https://doi.org/10.1371/journal.pone.0144857
  24. Mikhelson AF, Feoktistova TE, Lebedenko EYu, Mikhelson AA. Influence of the combination of estradiol valerate and dienogest on the frequency of relapses of hormone-sensitive polyps of the endometrium. Doktor RU. 2016;7(124):27-31. (In Russ.)
  25. Seravalli V, Linari S, Peruzzi EE, Dei Dei М, Bruni V. Prevalence of hemostatic disorders in adolescents with abnormal uterine bleeding. J Pediatr Adolesc Gynecol. 2013;26(5):285-289. https://doi.org/10.1016/j.jpag.2013.06.003
  26. Pestrikova TYu, Yurasova EA, Sukhonosova EL, Svidler NV. The possibility of using a contraceptive containing estradiol valerate and dienogest, in patients with polycystic ovary syndrome. The Russian bulletin of the obstetrician-gynecologist. 2013;13(5):75-77. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.